Specifically, it says " GCDx will have a GMP licensed manufacturing facility to make their own test reagents and will offer the new Lung Cancer Test in Month 3 following funding. "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.